Arcutis Biotherapeutics, Inc. · NASDAQ:ARQT
Matsuda Masaru sold 8,256 Arcutis Biotherapeutics, Inc. shares (Form 4)
Traded May 4, 2026 · Filed May 6, 2026
On May 4, 2026, Matsuda Masaru (See Remarks) sold 8,256 Arcutis Biotherapeutics, Inc. shares at an average US$23.31 for US$192K under a trading plan, leaving 126,689 shares. Filed May 6, 2026 (Form 4).
- Sold
- 8,256 shares
- Price
- US$23.31 average (US$23.27 to US$23.61)
- Value
- US$192K
- Holding after
- 126,689 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- See Remarks
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 4, 2026 | Common Stock | Sale | 7,372 | US$23.27 | 127,573 | Direct |
| May 4, 2026 | Common Stock | Sale | 884 | US$23.61 | 126,689 | Direct |
Source
Related
- Arcutis Biotherapeutics, Inc.
- Matsuda Masaru
- Arcutis Biotherapeutics, Inc. shareholders
- Form 4 · Matsuda Masaru · Sep 18, 2026
- Form 4 · Matsuda Masaru · Sep 10, 2026
- Form 4 · Matsuda Masaru · Aug 5, 2026
- Form 4 · Welgus Howard G. · Oct 19, 2026
- Schedule 13G/A · BlackRock, Inc. · Oct 5, 2026
- Form 4 · Welgus Howard G. · Sep 17, 2026
- Form 4 · Curran Terrie · Aug 28, 2026
- Form 4 · Curran Terrie · Aug 24, 2026